Wanbury Limited (WANBURY.BO)
INR 290.05
(-5.0%)
INR 290.05
(-5.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 820 Million INR | 3350.16% |
| 2022 | 23.76 Million INR | -42.46% |
| 2021 | 41.3 Million INR | -94.59% |
| 2020 | 763.15 Million INR | -23.33% |
| 2019 | 995.41 Million INR | -19.09% |
| 2018 | 1.23 Billion INR | 24.26% |
| 2017 | 990.11 Million INR | -35.6% |
| 2016 | 1.53 Billion INR | -26.15% |
| 2015 | 2.08 Billion INR | -23.04% |
| 2014 | 2.7 Billion INR | 0.0% |
| 2012 | 3.1 Billion INR | 18.92% |
| 2011 | 2.6 Billion INR | 57.65% |
| 2010 | 1.65 Billion INR | -64.7% |
| 2009 | 4.68 Billion INR | -0.82% |
| 2008 | 4.72 Billion INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 FY | 820 Million INR | 3350.16% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 820 Million INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 1 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 FY | 23.76 Million INR | -42.46% |
| 2022 Q4 | 23.76 Million INR | 0.0% |
| 2022 Q2 | 29.35 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 745.67 Million INR | 0.0% |
| 2021 FY | 41.3 Million INR | -94.59% |
| 2021 Q4 | 41.3 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q4 | 763.15 Million INR | 0.0% |
| 2020 Q2 | 868.01 Million INR | 0.0% |
| 2020 FY | 763.15 Million INR | -23.33% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 FY | 995.41 Million INR | -19.09% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q4 | 995.41 Million INR | 0.0% |
| 2019 Q2 | 1.13 Billion INR | 0.0% |
| 2018 Q4 | 1.23 Billion INR | 0.0% |
| 2018 FY | 1.23 Billion INR | 24.26% |
| 2017 FY | 990.11 Million INR | -35.6% |
| 2016 FY | 1.53 Billion INR | -26.15% |
| 2015 FY | 2.08 Billion INR | -23.04% |
| 2014 FY | 2.7 Billion INR | 0.0% |
| 2012 FY | 3.1 Billion INR | 18.92% |
| 2011 FY | 2.6 Billion INR | 57.65% |
| 2010 FY | 1.65 Billion INR | -64.7% |
| 2009 FY | 4.68 Billion INR | -0.82% |
| 2008 Q4 | 4.72 Billion INR | 0.0% |
| 2008 FY | 4.72 Billion INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Ajanta Pharma Limited | 235.2 Million INR | -248.639% |
| Amrutanjan Health Care Limited | 13.96 Million INR | -5770.561% |
| Sigachi Industries Limited | 265.79 Million INR | -208.505% |
| Bal Pharma Limited | 363.82 Million INR | -125.384% |
| Ind-Swift Laboratories Limited | 111.62 Million INR | -634.596% |
| Medico Remedies Limited | 8.67 Million INR | -9355.72% |
| Lasa Supergenerics Limited | - INR | -Infinity% |
| Venus Remedies Limited | 386.8 Million INR | -111.996% |
| Sun Pharma Advanced Research Company Limited | 106.6 Million INR | -669.231% |
| Alpa Laboratories Limited | - INR | -Infinity% |
| Nectar Lifesciences Limited | 1.4 Billion INR | 41.557% |
| Shilpa Medicare Limited | 5.6 Billion INR | 85.361% |
| Aarti Drugs Limited | 2.75 Billion INR | 70.218% |
| Lupin Limited | 1.55 Billion INR | 47.192% |
| Aurobindo Pharma Limited | 21.34 Billion INR | 96.159% |
| Zydus Lifesciences Limited | 251 Million INR | -226.693% |
| Windlas Biotech Limited | 20.18 Million INR | -3963.429% |
| Suven Life Sciences Limited | - INR | -Infinity% |
| Eris Lifesciences Limited | 6.54 Billion INR | 87.471% |
| Valiant Laboratories Limited | 746.63 Million INR | -9.827% |
| J. B. Chemicals & Pharmaceuticals Limited | 236.4 Million INR | -246.87% |
| Solara Active Pharma Sciences Limited | 1.05 Billion INR | 22.517% |
| Ipca Laboratories Limited | 5.8 Billion INR | 85.872% |
| Bliss GVS Pharma Limited | 355.92 Million INR | -130.388% |
| Achyut Healthcare Limited | - INR | -Infinity% |
| Sun Pharmaceutical Industries Limited | 13.3 Million INR | -6065.414% |
| Bajaj HealthCare Limited | 650.34 Million INR | -26.087% |
| RPG Life Sciences Limited | -30.3 Million INR | 2806.271% |
| Mankind Pharma Limited | 248.67 Million INR | -229.745% |
| Laurus Labs Limited | 8.6 Billion INR | 90.469% |
| Piramal Pharma Limited | 24.83 Billion INR | 96.699% |
| Syncom Formulations (India) Limited | -1.21 Million INR | 67368.253% |
| Torrent Pharmaceuticals Limited | 16.04 Billion INR | 94.888% |
| Alembic Pharmaceuticals Limited | 628.8 Million INR | -30.407% |
| Glenmark Pharmaceuticals Limited | 1.51 Billion INR | 45.943% |
| Unichem Laboratories Limited | 382.22 Million INR | -114.536% |
| Sequent Scientific Limited | 1.42 Billion INR | 42.544% |
| Novartis India Limited | 50.7 Million INR | -1517.357% |
| Suven Pharmaceuticals Limited | 212.35 Million INR | -286.144% |
| Wockhardt Limited | 8.91 Billion INR | 90.797% |
| Themis Medicare Limited | 267.74 Million INR | -206.267% |
| Jagsonpal Pharmaceuticals Limited | 75.57 Million INR | -985.087% |
| Jubilant Pharmova Limited | 31.67 Billion INR | 97.411% |
| Glenmark Life Sciences Limited | 147.61 Million INR | -455.518% |
| Dr. Reddy's Laboratories Limited | 5.99 Billion INR | 86.311% |
| Divi's Laboratories Limited | 20 Million INR | -4000.0% |
| NATCO Pharma Limited | 53 Million INR | -1447.17% |
| Gufic Biosciences Limited | 1.53 Billion INR | 46.74% |
| IOL Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Ind-Swift Limited | 10.09 Billion INR | 91.877% |
| Procter & Gamble Health Limited | 68.8 Million INR | -1091.86% |
| FDC Limited | 2.46 Million INR | -33152.23% |
| Krebs Biochemicals & Industries Limited | 1.83 Billion INR | 55.313% |
| Granules India Limited | 689.71 Million INR | -18.891% |
| Medicamen Biotech Limited | 12.55 Million INR | -6431.262% |
| Alkem Laboratories Limited | 400 Million INR | -105.0% |
| AstraZeneca Pharma India Limited | 27.83 Million INR | -2845.826% |
| Biofil Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Brooks Laboratories Limited | 3.56 Million INR | -22901.403% |
| Megasoft Limited | 1.35 Billion INR | 39.576% |
| ZIM Laboratories Limited | 356 Million INR | -130.333% |
| Strides Pharma Science Limited | 6.71 Billion INR | 87.789% |
| Neuland Laboratories Limited | 449.2 Million INR | -82.544% |
| Morepen Laboratories Limited | 33.64 Million INR | -2337.574% |
| Hikal Limited | 4.22 Billion INR | 80.608% |
| Indoco Remedies Limited | 3.51 Billion INR | 76.687% |
| Aarti Pharmalabs Limited | 400 Thousand INR | -204900.0% |
| Kilitch Drugs (India) Limited | - INR | -Infinity% |
| Mangalam Drugs & Organics Limited | 133.54 Million INR | -514.044% |
| Hester Biosciences Limited | 1.81 Billion INR | 54.889% |